Akèy › Kansè (tout kalite) › Ohio › Cleveland
Etid klinik pou Kansè (tout kalite) nan Cleveland, OH
36 etid pou Kansè (tout kalite) ap chèche patisipan nan sit nan ak bò kote Cleveland (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
Ap rekriteFaz 2
- University Hospitals Cleveland Medical Center /ID# 279601, Cleveland
A Study of ASP3082 in Adults With Advanced Solid Tumors
Ap rekriteFaz 1
- Case Western, Cleveland
A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
Ap rekriteFaz 1
- University Hospitals Cleveland Medical Center, Cleveland
Visugromab in Cachexia International Trial
Ap rekriteFaz 2/3
- Cleveland Clinic (Main Campus), Cleveland
- Cleveland Clinic Hillcrest Hospital, Mayfield Heights · 12 mi lwen
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Ap rekriteFaz 2/3
- University Hospitals of Cleveland, Cleveland
- Cleveland Clinic Foundation, Cleveland
Statins to Prevent Cancer Associated Blood Clots
Ap rekriteFaz 4
- Cleveland Clinic Foundation, Cleveland
Replacing Invasive Cystoscopy With Urine Testing for Non-muscle Invasive Bladder Cancer Surveillance
Ap rekriteFaz 2
- University Hospitals Cleveland Medical Center, Cleveland
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
Ap rekriteFaz 2
- Cleveland Clinic, Cleveland
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Ap rekriteFaz 1
- University Hospital Cleveland Medical Center, Cleveland
- Cleveland Clinic, Cleveland
A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
Ap rekriteEtid obsèvasyon
- Cleveland Clinic, Cleveland
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
Ap rekriteFaz 3
- Cleveland Clinic, Cleveland
Project: Every Child for Younger Patients With Cancer
Ap rekriteEtid obsèvasyon
- Rainbow Babies and Childrens Hospital, Cleveland
- Cleveland Clinic Foundation, Cleveland
A Study of REC-1245 in Participants With Unresectable, Locally Advanced, or Metastatic Cancer
Ap rekriteFaz 1/2
- Cleveland Clinic, Cleveland
Abatacept in Immune Checkpoint Inhibitor Myocarditis
Ap rekriteFaz 3
- Cleveland Clinic, Cleveland
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Ap rekriteFaz 1/2
- University Hospitals Cleveland Medical Center, Seidman Cancer Center, Cleveland
- Cleveland Clinic, Cleveland
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Ap rekriteFaz 3
- Case Western Reserve University, Cleveland
- Cleveland Clinic Cancer Center/Fairview Hospital, Cleveland
- Cleveland Clinic Foundation, Cleveland
- ak 3 plis
Repeat Breast Conserving Surgery Followed by Daily Partial Breast Irradiation in Ipsilateral Breast
Ap rekriteFaz 2
- University Hospitals Cleveland Medical Center, Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland
- Cleveland Clinic Taussig Cancer Center, Case Comprehensive Cancer Center, Cleveland
Feasibility and Acceptability of Wearable Sensors and ePROs in Early Phase Clinical Trials
Ap rekrite
- Case Comprehensive Cancer Center, Cleveland Clinic Foundation Taussig Cancer Institute, Cleveland
A Study of ASP1002 in Adults for Treatment of Solid Tumors
Ap rekriteFaz 1
- University Hospitals of Cleveland, Cleveland
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Ap rekriteFaz 1/2
- UH Cleveland Medical Center, Cleveland
A Clinical Study to Test if an Investigational Treatment Called BNT314 When Used in Combination With Another Investigational Treatment Pumitamig (BNT327) and Chemotherapy, is Beneficial and Safe for Patients With Advanced Colorectal Cancer
Ap rekriteFaz 1/2
- Cleveland Clinic Taussig Cancer Institute Case Comprehensive Cancer Center, Cleveland
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
Ap rekriteFaz 1/2
- University Hospitals Cleveland Medical Center, Cleveland
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
Ap rekrite
- Louis Stokes VA Medical Center, Cleveland, OH, Cleveland
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
Ap rekriteFaz 1
- University Hospitals - UH Cleveland Medical Center, Cleveland
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
Ap rekriteFaz 2
- Cleveland Clinic, Cleveland
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
Ap rekriteFaz 1/2
- Cleveland Clinic, Cleveland
Proton Therapy Patient Registry
Ap rekriteEtid obsèvasyon
- University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center, Cleveland
Suprachoroidal Administration in Subjects With Metastases to the Choroid
Ap rekriteFaz 2
- Cleveland Clinic, Cole Eye Institute, Cleveland
Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
Ap rekrite
- Louis Stokes VA Medical Center, Cleveland, OH, Cleveland
Caris Biorepository Research Protocol
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- Great Lakes Medical Research, Cleveland
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Ap rekriteEtid obsèvasyon
- Massive Bio SYNERGY-AI site, Mayfield Heights · 12 mi lwen
A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the Lungs
Ap rekriteFaz 1/2
- Cleveland Clinic, Cleveland
Promoting Access, Resources and Treatment Through Novel and Equitable Solutions for Cancer Care
Ap rekrite
- Case Comprehensive Cancer Center, Cleveland
Phase 1 Study Evaluating BA3182 in Patients With Advanced Adenocarcinoma.
Ap rekriteFaz 1
- University Hospitals Cleveland Medical Center, Cleveland
A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors
Ap rekriteFaz 1/2
- Cleveland Clinic, Cleveland
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Ap rekrite
- University Hospitals Cleveland Medical Centre, Cleveland
- University Hospitals Chagrin Highlands Medical Centre, Orange · 12 mi lwen
Etid Kansè (tout kalite) nan lòt vil
- Houston, TX121 etid
- New York City, NY110 etid
- Boston, MA86 etid
- Los Angeles, CA73 etid
- Nashville, TN65 etid
- Philadelphia, PA59 etid
- Durham, NC58 etid
- Washington, DC58 etid
- Chicago, IL51 etid
- Seattle, WA49 etid
- Atlanta, GA49 etid
- Arlington, VA48 etid
Lòt etid nan Cleveland
- Kansè Poumon ki pa ti selil43 etid
- Kansè nan tete35 etid
- Kansè pwostat34 etid
- Ensifizyans kadyak33 etid
- Kansè Metastatik30 etid
- Kansè ovè30 etid
- Kansè poumon26 etid
- Kansè kolorektal24 etid
- Maladi kadyovaskilè22 etid
- Kansè Endomèt20 etid
- Leksemi mieloïd egi20 etid
- Maladi Crohn19 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.